R-524

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameR-524
Drug Alias NamePKC theta inhibitor (Rigel Pharmaceuticals)protein kinase C theta inhibitor (Rigel Pharmaceuticals)R-524
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C theta inhibitors
TargetsProtein kinase C theta
Therapy Area/IndicationsGraft vs Host DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRigel Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRigel Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A